Douglas C. Lane & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $1.29M | Sell |
12,725
-856
| -6% | -$86.6K | 0.03% | 149 |
|
|
2015
Q3 | $1.33M | Sell |
13,581
-400
| -3% | -$39.3K | 0.04% | 145 |
|
|
2015
Q2 | $1.64M | Sell |
13,981
-185
| -1% | -$21.7K | 0.04% | 143 |
|
|
2015
Q1 | $1.39M | Buy |
14,166
+1,663
| +13% | +$163K | 0.04% | 139 |
|
|
2014
Q4 | $1.18M | Sell |
12,503
-9
| -0.1% | -$849 | 0.03% | 137 |
|
|
2014
Q3 | $1.33M | Buy |
12,512
+4,055
| +48% | +$432K | 0.04% | 137 |
|
|
2014
Q2 | $701K | Buy |
8,457
+1,086
| +15% | +$90K | 0.02% | 150 |
|
|
2014
Q1 | $522K | Sell |
7,371
-83
| -1% | -$5.88K | 0.02% | 158 |
|
|
2013
Q4 | $560K | Sell |
7,454
-960
| -11% | -$72.1K | 0.02% | 153 |
|
|
2013
Q3 | $529K | Sell |
8,414
-32
| -0.4% | -$2.01K | 0.02% | 152 |
|
|
2013
Q2 | $433K | Buy |
+8,446
| New | +$433K | 0.02% | 158 |
|